Regarding the effectiveness of ACP for children with pediatric tumors

JRCT ID: jRCT1040240006

Registered date:05/04/2024

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Leukemia, Malignant lymphoma, Aplastic Anemia, Cerebrospinal tumor, Neuroblastoma, Bone and soft tis
• Date of first enrollment: 04/03/2024
• Target sample size: 12
• Study type: Interventional

Intervention(s)

The intervention will be conducted over a total of three sessions.
session1 Conducted a card game to select values.
session2 Use cards called Moshi Bana Game to choose what you want to focus on during treatment.
session3 Find the strengths of your research subjects using Strength Cards.

Outcome(s)

Primary Outcome

Decisional Conflict Scale
Family Resilience Assessment Scale

Secondary Outcome

Beck Depression Inventory-2
Impact of Event Scale-Revised
Pediatric Quality of Life InventoryTM
Satisfaction Questionnaire

Key inclusion & exclusion criteria

• Age minimum: >= 13age old
• Age maximum: <= 25age old
• Gender: Both

Include criteria

Pediatric hematology oncology patients hospitalized in the Department of Pediatrics, Hamamatsu University School of
Medicine Hospital, and their families.
The child understands his or her medical condition.
Consent can be obtained from the patient and his or her legal guardian.
No significant intellectual delay or developmental retardation.
BDI-2 26 points or less
Those who have consented to participate in this research by signing a consent form
Those who have obtained consent to participate in this research by signing a consent form by themselves or their legal
guardian.

Exclude criteria

Severe suicidal ideation and suicidal behavior are observed.
have a serious mental illness
Children are not informed about their medical condition.

Related Information

• Primary Sponsor: Yamasue Hidenori
• Source(s) of Monetary Support: Grants-in-Aid for Scientific Research